Repeated criticism of self-medication drug prices is unjustified

Retail pharmacies currently face a negative environment, characterised by too frequent attacks on the price of self-medication drugs. In that context, and following continued allegations in the Report of the French Inspectorate General of Finances – the conclusions of which do not correspond to the findings of Afipa’s own studies – Afipa is keen to reiterate a number objective and verifiable facts.

Download document